Differences between revisions 1 and 5 (spanning 4 versions)
Revision 1 as of 2006-11-20 20:21:55
Size: 2177
Editor: lfrq80
Comment:
Revision 5 as of 2009-02-12 01:04:15
Size: 3695
Editor: localhost
Comment: converted to 1.6 markup
Deletions are marked like this. Additions are marked like this.
Line 16: Line 16:
[[TableOfContents([2])]] <<TableOfContents([2])>>
Line 26: Line 26:
 1. User
 1. ...
 1. ...
 1. User specifies a protein to transcribe
 1. User optionally specifies another species that originates the transcription process
 1. User specifies that there is a ../TranscriptionShorthand relationship between the two
 1. User optionally specifies the evidence for this reaction
Line 32: Line 33:

The symbol for ../TranscriptionShorthand is simular to ../ProductAppears, except that there are a pair of right angles near the head:

{{attachment:transcriptionshorthand1_061120_dwk.PNG}}

An example in context follows:

{{attachment:transcriptionshorthand3_061121_dwk.PNG}}

The ../TranscriptionShorthand hides many of the transcription details. So the following detailed representation show here:

{{attachment:transcriptionshorthand2_061120_dwk.PNG}}

Might be represented more simply as follows:

{{attachment:transcriptionshorthand2_061121_dwk.PNG}}

The ../TranscriptionShorthand concept differs from ../ProductAppears, in that in ../TranscriptionShorthand, the product must appear through transcription. In ../ProductAppears, the product may appear through any mechanism.
{{attachment:transcriptionshorthand4_061121_dwk.PNG}}
Line 42: Line 62:
TBD This is a fairly common structure, and is of moderate importance.
Line 52: Line 72:
----
GaryBader - 2006-12-26 12:26:48
 
This will be handled in BioPAX with the gene regulation proposal, currently under development for Level 3.
----
AllanKuchinsky - 2007-01-22 05:21:14
 
see my comments under TranscriptionInhibitionShorthand
Line 53: Line 81:
[[PageComment2]] Does there need to be a Cytoscape 'constant' node for 'mRNA'?  (see comments for SpeciesDegradation)

Use Case Name : ../TranscriptionShorthand

For Feature : MIMEditor

Editors: DavidKane

<<TableOfContents: execution failed [Argument "maxdepth" must be an integer value, not "[2]"] (see also the log)>>

Summary

A user wants to describe the possibility a protein is transcribed, without showing in detail, all of the mechanisms.

Step-by-Step User Action

  1. User specifies a protein to transcribe
  2. User optionally specifies another species that originates the transcription process
  3. User specifies that there is a ../TranscriptionShorthand relationship between the two

  4. User optionally specifies the evidence for this reaction

Visual Aides

The symbol for ../TranscriptionShorthand is simular to ../ProductAppears, except that there are a pair of right angles near the head:

transcriptionshorthand1_061120_dwk.PNG

An example in context follows:

transcriptionshorthand3_061121_dwk.PNG

The ../TranscriptionShorthand hides many of the transcription details. So the following detailed representation show here:

transcriptionshorthand2_061120_dwk.PNG

Might be represented more simply as follows:

transcriptionshorthand2_061121_dwk.PNG

The ../TranscriptionShorthand concept differs from ../ProductAppears, in that in ../TranscriptionShorthand, the product must appear through transcription. In ../ProductAppears, the product may appear through any mechanism. transcriptionshorthand4_061121_dwk.PNG

Requirements for Cytoscape

TBD

Importance

This is a fairly common structure, and is of moderate importance.

Other Examples

Comments

Shared ../MimEditorUseCaseComments

BioPax representation TBD


GaryBader - 2006-12-26 12:26:48

This will be handled in BioPAX with the gene regulation proposal, currently under development for Level 3.


AllanKuchinsky - 2007-01-22 05:21:14

see my comments under TranscriptionInhibitionShorthand

Does there need to be a Cytoscape 'constant' node for 'mRNA'?  (see comments for SpeciesDegradation)

Molecular_Interaction_Maps/TranscriptionShorthand (last edited 2009-02-12 01:04:15 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux